Fahim M, Khan M S, Hameed H A
Department of Physiology, Vallabbhai Patel Chest Institute, University of Delhi.
Indian J Physiol Pharmacol. 1995 Apr;39(2):101-5.
The effects of a herbal drug, Ajmaloon (Hamdard, India), on the arterial blood pressure, heart rate (HR) and baroreceptor-heart rate reflex were studied in anesthetized rabbits and monkeys. Intravenously administered Ajmaloon produced a dose-dependent hypotensive response in both the species without any significant effect on the heart rate. Only in high doses (200 mg/kg or more). Ajmaloon produced a bradycardia response in rabbits. Even the highest dose (300 mg/kg) of Ajmaloon used in the present investigation did not cause arrhythmia or any other conduction disorder or respiratory distress. Baroreflex SAP-HR curve was shifted to the left of the control following treatment with 100 mg/kg intravenous Ajmaloon in both the species. Loss of tachycardia response to fall in arterial pressure in Ajmaloon treated animals indicated the drug induced suppression of normally existing sympathetic excitatory influence in response to hypotension. Baroreflex regulatory HR response to hypertension remains intact after intravenous administration of 100 mg/kg Ajmaloon, a dose much higher than the prescribed highest oral dose for humans. Intact baroreflex regulation of arterial blood pressure in response to hypertension in Ajmaloon treated mammals suggests that in patients besides lowering the blood pressure. Ajmaloon might not interfere with the normal blood pressure regulatory mechanism through arterial baroreceptors during hypertension.
在麻醉的兔和猴身上研究了一种草药药物阿吉马隆(印度哈马德公司生产)对动脉血压、心率(HR)和压力感受器 - 心率反射的影响。静脉注射阿吉马隆在这两种动物中均产生剂量依赖性降压反应,对心率无显著影响。仅在高剂量(200毫克/千克或更高)时,阿吉马隆在兔中产生心动过缓反应。即使在本研究中使用的最高剂量(300毫克/千克)的阿吉马隆也未引起心律失常或任何其他传导障碍或呼吸窘迫。在两种动物中,静脉注射100毫克/千克阿吉马隆后,压力反射收缩压 - 心率曲线向左移至对照曲线左侧。阿吉马隆治疗的动物对动脉压下降的心动过速反应丧失表明该药物抑制了正常存在的对低血压的交感神经兴奋影响。静脉注射100毫克/千克阿吉马隆(该剂量远高于人类规定的最高口服剂量)后,压力反射对高血压的调节性心率反应保持完整。阿吉马隆治疗的哺乳动物对高血压的动脉血压压力反射调节完整表明,在患者中,除了降低血压外,阿吉马隆在高血压期间可能不会通过动脉压力感受器干扰正常的血压调节机制。